Order Article Reprints

Turchi L, Sakakini N, Saviane G, Polo B, Saurty-Seerunghen MS, Gabut M, Gouillou CA, Guerlais V, Pasquier C, Vignais ML, et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers. 2023; 15(20):5038. https://doi.org/10.3390/cancers15205038

Turchi, Laurent, Nathalie Sakakini, Gaelle Saviane, Béatrice Polo, Mirca Saras Saurty-Seerunghen, Mathieu Gabut, Corine Auge Gouillou, Vincent Guerlais, Claude Pasquier, Marie Luce Vignais, and et al. 2023. "CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3" Cancers 15, no. 20: 5038. https://doi.org/10.3390/cancers15205038

Turchi, L., Sakakini, N., Saviane, G., Polo, B., Saurty-Seerunghen, M. S., Gabut, M., Gouillou, C. A., Guerlais, V., Pasquier, C., Vignais, M. L., Almairac, F., Chneiweiss, H., Junier, M.-P., Burel-Vandenbos, F., & Virolle, T. (2023). CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers, 15(20), 5038. https://doi.org/10.3390/cancers15205038